Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 1 ~ 20 of 1141, Page 1 of 58
1. WHO recommends dolutegravir as preferred HIV treatment option in all populations
07/22/2019 WHO
2. FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) For the Treatment of Adults with Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections Where Limited or No Alternative Treatment Options Are Available
07/17/2019 MERCK
3. WHO updates global guidance on medicines and diagnostic tests to address health challenges, prioritize highly effective therapeutics, and improve affordable access
New essential medicines and diagnostics lists published today
07/09/2019 WHO
4. In the face of slow progress, WHO offers a new tool and sets a target to accelerate action against antimicrobial resistance
06/18/2019 WHO
5. Merck to Acquire Tilos Therapeutics
Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ
06/10/2019 MERCK
6. FDA approves treatment for patients with a type of inflammatory arthritis
03/28/2019 U.S. FOOD & DRUG ADMINISTRATION
7. FDA statement from Commissioner announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications
Risk Evaluation and Mitigation Strategy (REMS)
01/24/2019 U.S. FOOD & DRUG ADMINISTRATION
8. FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults...
11/28/2018 U.S. FOOD & DRUG ADMINISTRATION
9. Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on transformative new steps to modernize FDA’s 510(k) program to advance the review of the safety and effectiveness of medical devices
Modernizing the 510(k) Pathway“Safety and Performance Based Pathway” / Promoting Greater Transparency and Post-Market Surveillance
11/26/2018 U.S. FOOD & DRUG ADMINISTRATION
10. Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs
11/16/2018 U.S. FOOD & DRUG ADMINISTRATION
11. Patients with shoulder arthritis have new options to avoid risks of total shoulder replacement
A new review article published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) finds arthroscopic (joint replacement or reconstruction) management could be a promising option for young, active patients diagnosed with GHOA.
11/16/2018 American Academy of Orthopaedic Surgeons
12. New Approvals Allow Chronic Pain Sufferers to Try Abbott''s Non-Opioid Pain Therapy Before Getting Device Implant
Neurostimulation of the dorsal root ganglion (DRG) can provide pain relief for patients battling chronic pain when previous treatment options were unsuccessful / Abbott's new DRG Invisible Trial System brings an intuitive, wireless approach to the temporary evaluation giving patients the full benefits of DRG therapy prior to permanent implant
11/15/2018 Abbott
13. AMA President Outlines Efforts to Attack Dysfunction in Health Care
11/14/2018 American Medical Association
14. New $15 Million Initiative to Further Reimagine Physician Training
New AMA Reimagining Residency initiative is aimed at transforming residency training to ensure physician well-being and improved patient safety.
10/30/2018 American Medical Association (AMA)
15. The overlooked benefits of medical scribes
It''s a given that using medical scribes will reduce data-entry time for physicians. But the myriad benefits this produces for patients and physicians are now being quantified by emerging research.
10/26/2018 American Medical Association (AMA) News by Andis Robeznieks
16. Privacy, security guidelines aim to bolster use of mHealth
Privacy and security guidelines aimed at securing the protected health information and personal, identifiable data of mobile health app users have been released for public comment by Xcertia, a nonprofit founded by the AMA and other major health and technology organizations.
10/25/2018 American Medical Association (AMA) News by Andis Robeznieks
17. Survey reveals top 6 challenges faced in medical residency
For three in five medical residents, nonclinical concerns such as work-life balance, time pressures or debt represent their biggest challenge during in training.
10/25/2018 American Medical Association (AMA) News by Brendan Murphy
18. Strict EU ruling on gene edited crops squeezes science
Researchers are feeling the pinch and demanding exemptions for plant science and agriculture.
10/25/2018 Nature News by Andrew J Wight
19. FDA Approves New SynchroMed(TM) II myPTM(TM) Personal Therapy Manager That Enables Patients to Alleviate Unpredictable Pain
(GLOBE NEWSWIRE via COMTEX) --myPTM Allows Patients to Personalize Their Treatment by Delivering On-Demand Boluses, or Drug Doses, Within Therapeutic Limits Set by Their Physician
10/24/2018 Medtronic
20. Satisfaction in science
Nature''s survey offers a snapshot of salaries and career paths in the scientific sector.
10/24/2018 Nature: Career Feature by Chris Woolston
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱